Ergoteles LLC Medpace Holdings, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $6.25 Million - $8.01 Million	33,365 New	33,365 $8.01 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $1.89 Million - $2.37 Million	12,999 Added 75.62%	30,188 $4.75 Million
Q2 2022 Aug 12, 2022	BUY	$130.2 - $168.03 $1.68 Million - $2.17 Million	12,916 Added 302.27%	17,189 $2.57 Million
Q1 2022 May 13, 2022	BUY	$138.87 - $214.31 $370,227 - $571,350	2,666 Added 165.9%	4,273 $699,000
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $293,663 - $366,235	1,607 New	1,607 $350,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.